Health Trials

ALK-TKI

1

Review clinical trials related to ALK-TKI. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia

To assess the clinical efficacy of add-on topical timolol 0.5% eye drops to betamethasone valerate 0.1% for the treatment of EGFR-TKI and ALK-TKI induced paronychia.

Participants needed: 40
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Queen Mary Hospital, Hong KongUpdated: Oct 18, 2024Locations: 1
Eligibility criteria

Aged 18 years or above, either males or females. [+4]

1. Age below18 [+4]

Read more